The packaged-foods merger makes sense from a strategic standpoint, says Morningstar markets editor Jeremy Glazer. Plus, the Fed guessing game continues, and more.
In the immuno-oncology market, first movers and companies that can aggregate a portfolio of these types of therapies will probably be the long-term winners.
Recent data looks a little soft, but a better housing market should buoy up the weaker areas of the economy and make for a steady, staid 2015, says Morningstar's Bob Johnson.
International funds outpaced domestic, small-cap bested large-cap, and growth beat value.
ITC boasts much higher returns on capital and significantly lower risk than other utilities thanks to its friendlier regulatory situation, says Morningstar's Matt Coffina.
Leveraging Heinz's more extensive global footprint and efficient operations should help Kraft expand its earnings and competitive advantage, says Morningstar's Erin Lash.
Sales growth in the organic-food space should prove to be sustainable over the long term, but the related stocks are currently overvalued.
Silver-rated Gateway Fund's 30-year track record demonstrates viability across full market cycles.
Ask yourself when you'll need the money, what your future tax bracket may be, and where you'll find the money to pay the taxes due upon conversion, says retirement expert Ed Slott.
Investors should control for real risk--namely, the risk of losing money--at all times in their portfolios, says Oaktree's Howard Marks.